RT Journal Article
SR Electronic
T1 Mechanisms of Resistance to PARP Inhibitors—Three and Counting
JF Cancer Discovery
JO CANCER DISCOVERY
FD American Association for Cancer Research
SP 20
OP 23
DO 10.1158/2159-8290.CD-12-0514
VO 3
IS 1
A1 Fojo, Tito
A1 Bates, Susan
YR 2013
UL http://cancerdiscovery.aacrjournals.org/content/3/1/20.abstract
AB Summary: Given the malleable nature of cancer cells, we should expect, and do see, the development of resistance to any new chemotherapeutic agent. Models that help us understand how this happens are a first step to better and more effective chemotherapeutics. Cancer Discov; 3(1); 20–3. ©2012 AACR. See related article by Jaspers et al., p. 68